/Companies

Rubitection

Techstars '20

Rochester, US · Founded 2011 · 4 employees on LinkedIn · 2 known investors

Find your way into Rubitection

Sign up to see every warm intro you have to Rubitection

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Rubitection team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Rubitection develops the Rubitect Assessment System for early detection and management of pressure injuries (bedsores) in healthcare settings. The company serves healthcare providers and institutions focused on wound care and patient monitoring.

Also known as Rubitection Inc

Founders & leadership

Rubitection was founded in 2011 by Sanna Gaspard.

SGSanna Gaspard
Sanna GaspardCEO
YHYannick Heintz
Yannick HeintzData Scientist Manager

Board

JGJosh Ghaims
Josh GhaimsTechnology Advisor

Investors · 2

Techstarslisted by TechstarsBoulder · $220K

How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us

Company profile

researched Sep 2026

Rubitection is a healthcare technology company developing the Rubitect Assessment System (RAS), an early skin health monitoring and care management platform. The system pairs a low-cost, easy-to-use handheld measurement probe with care management software, giving caregivers and healthcare professionals data to support early skin assessment, personalize care, and enable prevention across care environments. The company positions the platform as an alternative to the manual blanch test used for bedsore detection.

The approach rests on skin redness — or hyperpigmentation on darker skin tones — as an early indicator and predictor of skin-related injuries and conditions in wound care, dermatology, and plastic surgery. Initial applications target the prevention of bedsores (pressure injuries) and diabetic foot ulcers, with additional stated applications in vascular leg ulcers and chronic dermatological conditions. The company describes the current platform as an AI assessment and care coordination platform covering wound prevention and monitoring, dermatology care, and vascular health monitoring.

Rubitection's stated mission is to become a global standard system for skin health monitoring and care management for wounds and chronic dermatological skin conditions.

Founding story

Rubitection was founded by Sanna Gaspard, PhD, who earned a bachelor's degree in biomedical engineering at the University of Miami (2004) and a master's (2005) and PhD (2011) in biomedical engineering at Carnegie Mellon University. While completing her graduate degrees she founded and led two biotech companies, TLneoCare, LLC and Rubitection Inc., to commercialize her innovations, developing the business strategy, IP strategy, and raising initial financing. Her stated vision is to make the Rubitect Assessment System the global standard solution for early bedsore detection and management.

Traction

The company reported $440,000 raised as of January 1, 2025 on its TechCrunch Startup Battlefield profile, and is listed at pre-seed stage with 1-10 employees.

Latest developments

The company's website presents the offering as an AI assessment and care coordination platform for skin-related and vascular health conditions, spanning wound prevention and monitoring, dermatology, and vascular health, and is recruiting beta testers.

▸Full profile — market position, technology, go-to-market, geography

Market position

Rubitection is an early-stage, pre-seed medical device and health technology company positioning its system as a superior alternative to the manual blanch test for bedsore detection, in a market where treating a single bedsore can cost up to $45,000.

Technology

The Rubitect Assessment System consists of a handheld measurement probe and accompanying care management software. The company describes the platform as using AI to deliver care insights and states it develops proprietary risk-based algorithms supported by clinical data analysis, work led by its data scientist manager. The underlying clinical signal is skin redness or hyperpigmentation, used as an early indicator of skin injury or inflammation.

Go-to-market

The company recruits beta testers for its platform through its website and maintains a newsletter and listed partners. It has participated in startup accelerator and competition programs, including the Luminate accelerator (cohort 3) and TechCrunch Startup Battlefield.

Caregivers and healthcare professionals responsible for skin assessment and care management, spanning wound care, dermatology, plastic surgery, and cosmetics settings; the company also targets patients at risk of bedsores, diabetic foot ulcers, and vascular leg ulcers.

Geography

Listed locations include Pittsburgh, Pennsylvania and Rochester, New York in the United States.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Employee count rangeJan 20241-10
Funding stageJan 2024Pre Seed
HeadcountAug 20264
Total funding raisedJan 2025$440K

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2016$221.4K
National Science FoundationPhase I2013$150K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Timeline · 3

launches, deals, and filings
Mar 2021
Featured in Luminate accelerator spotlight

Luminate published a spotlight and podcast on Rubitection, a Luminate cohort 3 startup, covering the Rubitect Assessment System and the CEO's accelerator experience.

source ↗

Jan 2013
Founder named finalist for Cartier Women's Initiative Awards

CEO Sanna Gaspard was selected as a finalist for the Cartier Women's Initiative Awards.

source ↗

Jan 2011
First place at 3 Rivers Investment Venture Fair technology showcase

CEO Sanna Gaspard took 1st place at the 3 Rivers Investment Venture Fair's Technology showcase.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

▸Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Rubitection do?
Rubitection builds the Rubitect Assessment System, a probe-and-software platform for early bedsore and skin health assessment.
Who founded Rubitection?
Rubitection was founded by Sanna Gaspard in 2011.
Who are Rubitection's investors?
Rubitection's investors include D3VC, Techstars.
Where is Rubitection headquartered?
Rubitection is headquartered in Rochester, US.